Profound Medical (TSE:PRN) Trading Up 0.3% – Should You Buy?

Profound Medical Corp. (TSE:PRN)’s stock price rose 0.3% during mid-day trading on Tuesday . The company traded as high as C$9.53 and last traded at C$9.43. 8,013 shares traded hands during trading, a decline of 50% from the average session volume of 16,107 shares. The stock had previously closed at C$9.40.

Profound Medical Stock Up 0.3%

The stock has a market cap of C$342.67 million, a price-to-earnings ratio of -7.60 and a beta of 1.26. The business’s 50 day moving average is C$9.45 and its 200-day moving average is C$9.50. The company has a debt-to-equity ratio of 12.56, a quick ratio of 14.98 and a current ratio of 6.56.

Profound Medical (TSE:PRN) last posted its quarterly earnings data on Thursday, May 7th. The company reported C$0.26 earnings per share for the quarter. Profound Medical had a negative net margin of 206.94% and a negative return on equity of 78.75%. The company had revenue of C$7.42 million during the quarter. On average, sell-side analysts predict that Profound Medical Corp. will post -1.9000001 EPS for the current fiscal year.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.